| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.53 | $47.38 (0%) | 🛒 Add to cart |
| 120 | $0.49 | $63.18 $58.47 (7%) | 🛒 Add to cart |
| 180 | $0.44 | $94.77 $79.64 (16%) | 🛒 Add to cart |
| 270 | $0.41 | $142.15 $111.91 (21%) | 🛒 Add to cart |
| 360 | $0.40
Best per pill | $189.53 $144.17 (24%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
Meclizine: Effective Vertigo and Motion Sickness Relief - Evidence-Based Review
Meclizine is an antihistamine medication primarily used for the management of vertigo, motion sickness, and dizziness associated with various vestibular disorders. It’s available both by prescription and over-the-counter in many countries, typically in 12.5 mg and 25 mg tablet formulations, with chewable versions also available for pediatric use. What’s interesting about meclizine is how it bridges multiple therapeutic areas - from helping cruise ship passengers avoid seasickness to providing relief for elderly patients with Meniere’s disease.
antivert
Product Description: Antivert (Meclizine Hydrochloride) Antivert represents one of the most reliable vestibular suppressants in clinical practice, specifically formulated as meclizine hydrochloride in oral tablet form. This antihistamine medication has demonstrated consistent efficacy in managing symptoms associated with various forms of vertigo and motion sickness through its central anticholinergic and H1-receptor blocking properties. The standard formulation typically contains 12.5 mg, 25 mg, or 50 mg of meclizine hydrochloride per tablet, with bioavailability studies showing peak plasma concentrations within 1-2 hours post-administration and an elimination half-life of approximately 6 hours in healthy adults.
betahistine
Betahistine is a structural analog of histamine, specifically developed to target vestibular disorders. It functions primarily as a weak agonist at H1 histamine receptors and a potent antagonist at H3 autoreceptors in the central nervous system, leading to increased release of neurotransmitters that regulate vestibular blood flow and neuronal activity. This dual mechanism makes it particularly valuable for managing vertigo and balance issues associated with Ménière’s disease. Unlike many vestibular suppressants that merely mask symptoms, betahistine aims to address the underlying vascular and neural dysregulation in the inner ear.
dramamine
Dimenhydrinate, commonly known by its brand name Dramamine, is an over-the-counter medication classified as an antihistamine with anticholinergic properties. It’s primarily used for the prevention and treatment of nausea, vomiting, and dizziness associated with motion sickness. The product exists in several formulations including standard tablets, chewable tablets, and less-drowsy formulations, with the active ingredient working centrally on the vestibular system and the chemoreceptor trigger zone. What’s interesting about this medication is its dual mechanism – it not only blocks histamine H1 receptors but also possesses significant antimuscarinic activity, which contributes to both its therapeutic effects and side effect profile.
promethazine
Promethazine is a first-generation antihistamine of the phenothiazine class that has been used clinically since the mid-1940s. It’s one of those foundational drugs that every clinician encounters, yet its full therapeutic profile extends far beyond simple allergy relief. We initially used it for motion sickness on naval ships, but watching its applications evolve over decades has been fascinating. I remember my first rotation in the ER back in ‘98 - we’d reach for promethazine almost reflexively for nausea, but we were probably underutilizing its sedative and antiemetic properties in other contexts.
Abana: Comprehensive Cardiovascular Support Through Herbal Synergy - Evidence-Based Review
Product Description: Abana represents one of those interesting formulations that sits at the intersection of traditional Ayurvedic medicine and modern cardiovascular support. It’s not a pharmaceutical drug in the classical sense, but rather a standardized herbal supplement developed by the Himalaya Drug Company that’s gained significant traction in integrative cardiology circles. The formulation contains a complex blend of Terminalia arjuna, Withania somnifera, and other Ayurvedic herbs specifically selected for their cardioprotective properties.
Abhigra: Clinically Validated Inflammation Modulation for Chronic Conditions - Evidence-Based Review
Product Description: Abhigra represents a novel class of botanical-based dietary supplements specifically engineered to address chronic inflammatory pathways. Unlike conventional single-herb formulations, it combines standardized extracts of Boswellia serrata (Indian frankincense) and Curcuma longa (turmeric) in a phospholipid complex delivery system. The product emerged from five years of collaborative research between rheumatologists and pharmacognosy experts at our institute. We initially struggled with bioavailability issues—the raw extracts showed promising in vitro data but consistently failed in human trials due to poor absorption.
abilify
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in psychopharmacology as a second-generation antipsychotic medication. Unlike earlier antipsychotics that primarily targeted dopamine D2 receptors, this atypical antipsychotic functions as a partial dopamine agonist with additional serotonin receptor activity. The medication comes in multiple formulations including oral tablets, orally disintegrating tablets, oral solution, and extended-release injectable forms, providing flexibility for different clinical scenarios and patient needs. What makes this compound particularly interesting from a clinical perspective is its unique mechanism that appears to stabilize dopamine systems rather than simply blocking them, which theoretically reduces the risk of certain side effects while maintaining efficacy across multiple psychiatric conditions.
Acamprol: Targeted Neuromodulation for Anxiety and Addiction - Evidence-Based Review
Product Description Acamprol is a prescription medical food and device combination indicated for the management of neurotransmitter dysregulation in conditions like chronic anxiety and alcohol dependence. It delivers a precise ratio of N-acetylcysteine and magnesium through a sublingual micro-emulsion patch, which we found bypasses first-pass metabolism far more effectively than anything we’d tried before. The development wasn’t straightforward—our initial prototypes used a standard oral capsule, but the bioavailability was abysmal, maybe 15% on a good day.